Key facts
- AI executives and biotech experts called for mandatory safety screening for synthetic DNA purchases.
- The appeal to the US Congress highlights the risk of AI advancements enabling bioweapon development.
- Signatories include leaders from Google DeepMind, OpenAI, Anthropic, and Microsoft AI.
- Synthetic DNA can be ordered online and shipped, posing global biosecurity risks.
- Current screening measures are voluntary, and the letter advocates for mandatory record-keeping.
- AI systems are improving rapidly and could significantly erode knowledge barriers for creating dangerous pathogens.
Executives from major AI companies, including OpenAI, Google DeepMind, Anthropic, and Microsoft AI, have united with biotechnology and national security experts to call for mandatory safety screening for synthetic DNA purchases. In a letter addressed to the US Congress, they expressed concerns that rapid advancements in artificial intelligence could significantly lower the barriers to developing biological weapons. Synthetic DNA, which can be ordered online, has numerous legitimate applications in research and medicine, but the signatories warned that malicious actors could potentially use it to recreate dangerous pathogens. While some companies voluntarily screen orders, the letter advocates for legally mandated screening and record-keeping to enhance biosecurity and deter misuse. The signatories emphasized that AI systems are increasingly capable of understanding complex laboratory procedures, which could exacerbate the bioweapons risk by eroding the knowledge and skill requirements historically limiting access to such capabilities.